ROBERT LANGER Insider Trading $ACTC Ocata Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT LANGER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT LANGER. ROBERT LANGER is Director in Ocata Therapeutics, Inc. ($ACTC) and Director in Lyra Therapeutics, Inc. ($LYRA) and Director in BIND Therapeutics, Inc ($BIND) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Director in Moderna, Inc. ($MRNA) and Director in Frequency Therapeutics, Inc. ($FREQ) and Director in Rubius Therapeutics, Inc. ($RUBY) and Director in Seer, Inc. ($SEER).
ROBERT LANGER in Ocata Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT LANGER: Director
Holdings: 0 shares
Latest Transaction: Feb 11 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ROBERT LANGER in Ocata Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BIND, FREQ, KALA, LYRA, MRNA, ACTC, RUBY, SEER
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 8.36 | 5,000 | 41,800 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 6.39 | 5,000 | 31,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 6.17 | 5,000 | 30,850 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 5.79 | 5,000 | 28,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 9.00 | 5,000 | 45,000 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 20.00 | 20,000 | 400,000 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 14.30 | 1,250 | 17,875 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Sell | U | 8.50 | 51,000 | 433,500 | 0 | 51 K to 0 (-100.00 %) |
| Jan 04 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | A | 8.36 | 5,000 | 41,800 | 5,000 | |
| Jan 04 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Grant | A | 0.00 | 1,250 | 0 | 52,250 | 51 K to 52.3 K (+2.45 %) |
| Oct 01 2015 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Grant | A | 0.00 | 1,250 | 0 | 51,000 | 49.8 K to 51 K (+2.51 %) |
| Jul 02 2015 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Grant | A | 0.00 | 1,250 | 0 | 49,750 | 48.5 K to 49.8 K (+2.58 %) |
| Apr 01 2015 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Grant | A | 0.00 | 1,250 | 0 | 48,500 | 47.3 K to 48.5 K (+2.65 %) |
Page: 1